Evidence map›Paper›PMID 39912987›Full record

ArticleAdvances in therapy2025

Are Treatment Adherence Factors Apparent in Patients with Asthma and to Physicians? Results from the APPaRENT 3 Survey.

Mohamed Al-Moamary, Bhumika Aggarwal, Mona Al-Ahmad, Thitiwat Sriprasart, Steven Koenig, Gur Levy, Abhay Phansalkar, Mark Silvey, Gary Milligan

Abstract read
In one paragraph

Article in Advances in therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohamed Al-MoamaryDepartment of Medicine, College of Medicine, King Saudi bin Abdulaziz University for Health Sciences, PO Box 84252, 11671, Riyadh, Kingdom of Saudi Arabia. almoamary@yahoo.com.ORCID 0000-0002-6919-7978
Bhumika AggarwalGeneral Medicines, GSK, Singapore, Singapore.
Mona Al-AhmadMicrobiology Department, College of Medicine, Kuwait University, Kuwait City, Kuwait.
Thitiwat SriprasartDepartment of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Steven KoenigUK St. Claire, Morehead, KY, USA.
Gur LevyGSK, Ciudad de Panamá, Panamá.
Abhay PhansalkarGSK, Mumbai, India.
Mark SilveyAdelphi Real World, Bollington, UK.
Gary MilliganAdelphi Real World, Bollington, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatient adherence to regular controller medication is critical for improving clinical outcomes in asthma, which is consistently associated with underlying pathophysiological inflammation. This survey aimed to identify types of treatment nonadherence and associated factors, including patient characteristics that predict poor adherence, in patients with asthma.

methodsThis cross-sectional online survey involved patients with asthma and physicians managing such patients from Southeast Asia (Indonesia, Malaysia, Philippines, Thailand and Vietnam) and the Middle East (Saudi Arabia and United Arab Emirates) included in the Asthma Patients' and Physicians' Perspectives on the Burden and Management of Asthma (APPaRENT) 3 study. Patients and physicians shared their attitudes and beliefs regarding treatment and adherence in asthma management.

resultsMost patients (82%, 1108/1354) reported having ever received treatment with daily controller inhalers, whereas 38% used inhaled relievers at least once daily for symptomatic relief. Among those prescribed maintenance and reliever therapy, 93% were prescribed a separate inhaled reliever, with significant variation by country (P < 0.01). Erratic nonadherence (primary definition) was exhibited by 55% (462/845) of patients including those who reported at least sometimes forgetting inhaler use, with its prevalence increasing with worsening asthma severity. Nonerratic nonadherence was exhibited by 49% (415/847) of patients including those who reported using controller inhalers less than once daily. Physicians reported that 73% of patients adhered to the prescribed regular medication. Regression analysis examining both erratic (primary definition) and nonerratic nonadherence revealed that current inhaled reliever used was the only significant predictor of poor adherence (P = 0.04). Sensitivity analyses revealed that the predictors of poor adherence to controller inhaler varied depending on the definition of nonadherence employed in the study.

conclusionThis study revealed high rates of erratic and nonerratic nonadherence to regular controller inhalers in patients with asthma as well as discordance between adherence rates reported by patients and physicians.

Indexed as

Anti-Asthmatic AgentsAsthmaMedication AdherenceAdministration, InhalationAdultAgedAttitude of Health PersonnelCross-Sectional StudiesFemaleHumansMaleMiddle AgedYoung AdultAnti-Asthmatic AgentsAsthmaAsthma action planICS-based controllersInhaled corticosteroidInhalerManagementNonadherencePhysician–patient relationshipTreatment adherence

Identifiers

PMID39912987
PMCPMC11868149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.